Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

NCT00845663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Certolizumab pegol
DRUG: Certolizumab pegol

Sponsor

UCB Pharma